Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
28.9M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
318K
-
Shares change
-
-3.63K
-
Total reported value, excl. options
-
$700K
-
Value change
-
-$8.83K
-
Number of buys
-
11
-
Number of sells
-
-3
-
Price
-
$2.20
Significant Holders of MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share (MAIA) as of Q3 2023
16 filings reported holding MAIA - MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q3 2023.
MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share (MAIA) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 318K shares
of 28.9M outstanding shares and own 1.1% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (93.5K shares), Centric Wealth Management (64.7K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (51.6K shares), GEODE CAPITAL MANAGEMENT, LLC (44.6K shares), Naviter Wealth, LLC (22.2K shares), FNY Investment Advisers, LLC (17.6K shares), BlackRock Inc. (14K shares), MORGAN STANLEY (5.1K shares), Tower Research Capital LLC (TRC) (4.92K shares), and UBS Group AG (133 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.